Grad Intern - Inflammation R&D (Summer 2027)
Amgen
Summary
During this program, you will apply your doctoral training to investigate immune cell function and mechanisms of inflammation, leading a defined wet-lab research project with scientific mentorship to support Amgen's mission to serve patients.
Job description
What You Will Do
During this program, you will apply your doctoral training to investigate immune cell function and mechanisms of inflammation, leading a defined wet-lab research project with scientific mentorship to support Amgen's mission to serve patients.
- Develop and execute a hypothesis-driven research project in immune cell biology and inflammation, in partnership with a scientist mentor
- Design, optimize, and troubleshoot project-relevant assays using cellular and molecular immunology techniques, including primary cell isolation from tissues, in vitro immunological assays, and multi-parameter flow cytometry
- Apply appropriate experimental controls and quantitative analyses to generate reproducible data and distinguish among potential biological mechanisms
- Integrate experimental findings with published literature, evaluate alternative interpretations, and propose follow-up studies that inform the project's scientific direction
- Maintain clear, traceable experimental records and communicate results, limitations, and recommendations through team discussions and a final research presentation
- Collaborate with scientists across the team while taking increasing ownership of the project and following laboratory safety procedures
Program Eligibility Requirements
- Must be available to work a full-time schedule
- Expected continued enrollment in an accredited college or university following the internship program / co-op
- Student must be located in the United States for the duration of the internship program
Basic Qualifications
- 18 years or older
- Graduated with a bachelor's degree from an accredited college or university
- Currently enrolled in an MBA program for an MBA internship OR a Master's program for a Master's internship OR a PharmD program for a PharmD internship OR Ph.D. for a PhD internship from an accredited college or university and completion of the first year of MBA OR Master's OR Pharm D OR Ph.D. program before the internship starts
Preferred Qualifications
- Pursuing PhD with degree concentration(s) in immunology, inflammation, cell biology, molecular biology, or a related biomedical field
- Hands-on research experience with one or more of the following: Primary cell isolation and enrichment, tissue processing immune functional assays, qRT-PCR, flow cytometry, protein biochemistry, molecular cloning and reporter assays, Western blotting, ELISA, cell culture, or in vivo mouse models
- Demonstrated ability to design controlled experiments, optimize or troubleshoot assays, and critically interpret biological data, including alternative explanations and appropriate statistical analyses
- Ability to organize and document research, communicate findings clearly, and work independently and collaboratively; proficiency with relevant analysis software such as GraphPad Prism, FlowJo, or equivalent tools
Requirements
- 18 years or older
- Graduated with a bachelor's degree from an accredited college or university
- Currently enrolled in an MBA, Master's, PharmD, or PhD program and completion of the first year before the internship starts
- Must be available to work a full-time schedule
- Expected continued enrollment in an accredited college or university following the internship
- Student must be located in the United States for the duration of the internship
- Candidates must be authorized to work in the U.S. for the duration of this program
Benefits
- Professional growth support
- Networking events
- Community volunteer projects
- Collaborative culture
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.